Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Variant form of hairy cell leukemia.

Wiber M, Maitre E, Cornet E, Salaün V, Naguib D, Troussard X.

Clin Case Rep. 2019 May 6;7(6):1161-1166. doi: 10.1002/ccr3.2176. eCollection 2019 Jun.

2.

Usefulness of Flow Cytometry for the Detection of Cutaneous Localization in Malignant Hematologic Disorders.

Maitre E, Le-Page AL, Comoz F, Truquet F, Damaj G, Cornet E, Verneuil L, Salaün V, Troussard X.

Cytometry B Clin Cytom. 2019 Jul;96(4):283-293. doi: 10.1002/cyto.b.21784. Epub 2019 May 3.

PMID:
31050147
3.

[Evaluation of management disparity in patients with chronic lymphocytic leukemia in France].

Rateau Y, Harbouche M, Damaj G, Troussard X.

Bull Cancer. 2018 Dec;105(12):1147-1156. doi: 10.1016/j.bulcan.2018.08.014. Epub 2018 Nov 2. French.

PMID:
30396506
4.

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia.

Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Karlin L, Robak T, Gladstone DE, le Coutre P, Dietrich S, Gotic M, Larratt L, Offner F, Schiller G, Swords R, Bacon L, Bocchia M, Bouabdallah K, Breems DA, Cortelezzi A, Dinner S, Doubek M, Gjertsen BT, Gobbi M, Hellmann A, Lepretre S, Maloisel F, Ravandi F, Rousselot P, Rummel M, Siddiqi T, Tadmor T, Troussard X, Yi CA, Saglio G, Roboz GJ, Balic K, Standifer N, He P, Marshall S, Wilson W, Pastan I, Yao NS, Giles F.

Leukemia. 2018 Aug;32(8):1768-1777. doi: 10.1038/s41375-018-0210-1. Epub 2018 Jul 20.

5.

New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes.

Maitre E, Bertrand P, Maingonnat C, Viailly PJ, Wiber M, Naguib D, Salaün V, Cornet E, Damaj G, Sola B, Jardin F, Troussard X.

Oncotarget. 2018 Jun 22;9(48):28866-28876. doi: 10.18632/oncotarget.25601. eCollection 2018 Jun 22.

6.

Adolescent and young adult oncology patients in France: Heterogeneity in pathways of care.

Desandes E, Brugières L, Molinié F, Defossez G, Delafosse P, Jehannin-Ligier K, Velten M, Trétarre B, Amadéo B, Marrer E, Woronoff AS, Ganry O, Monnereau A, d'Almeida T, Troussard X, Daubisse-Marliac L, Bara S, Guizard AV, Baldi I, Launoy G, Clavel J, Lacour B.

Pediatr Blood Cancer. 2018 Sep;65(9):e27235. doi: 10.1002/pbc.27235. Epub 2018 May 17.

PMID:
29770995
7.

Use of a case-mix approach to study the trends in the incidence of second primary cancers.

Gass B, Marrer E, Bara S, Ligier K, Molinié F, Colonna M, Daubisse-Marliac L, Trétarre B, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bouvier V, Troussard X, Gaiddon C, Klein D, Velten M, Jégu J.

Ann Epidemiol. 2018 May;28(5):322-327. doi: 10.1016/j.annepidem.2018.02.008. Epub 2018 Feb 15.

PMID:
29550348
8.

A retrospective study on the management of patients with rituximab refractory follicular lymphoma.

Solal-Céligny P, Leconte P, Bardet A, Hernandez J, Troussard X.

Br J Haematol. 2018 Jan;180(2):217-223. doi: 10.1111/bjh.15023. Epub 2017 Dec 12.

PMID:
29230799
9.

A mouse model of disseminated mantle cell lymphoma highlights a lack of activity of estrogen receptor β agonists toward tumor burden.

Body S, Esteve-Arenys A, Recasens-Zorzo C, Troussard X, Roué G, Sola B.

Leuk Lymphoma. 2018 Jul;59(7):1726-1729. doi: 10.1080/10428194.2017.1399313. Epub 2017 Nov 22. No abstract available.

PMID:
29164964
10.

Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.

Troussard X, Cornet E.

Am J Hematol. 2017 Dec;92(12):1382-1390. doi: 10.1002/ajh.24936.

11.

Methodological issues of assessing the risk of a second cancer occurring in the same site as a first cancer using registry data.

Jégu J, Moitry M, Bara S, Trétarre B, Guizard AV, Woronoff AS, Daubisse-Marliac L, Bouvier V, Troussard X, Colonna M, Klein D, Lapôtre-Ledoux B, Velten M.

Cancer Epidemiol. 2017 Dec;51:41-43. doi: 10.1016/j.canep.2017.10.004. Epub 2017 Oct 14.

PMID:
29032320
12.

Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.

Augustin A, Le Gouill S, Gressin R, Bertaut A, Monnereau A, Woronoff AS, Trétarre B, Delafosse P, Troussard X, Moreau A, Hermine O, Maynadié M.

J Cancer Res Clin Oncol. 2018 Apr;144(4):629-635. doi: 10.1007/s00432-017-2529-9. Epub 2017 Oct 11.

PMID:
29022078
13.

Recommendations for cerebrospinal fluid examination in acute leukemia.

Girard S, Fenneteau O, Mestrallet F, Troussard X, Lesesve JF.

Ann Biol Clin (Paris). 2017 Oct 1;75(5):503-512. doi: 10.1684/abc.2017.1250. Review.

PMID:
28853417
14.

Survival of patients with cancer starting chronic dialysis: Data from kidney and cancer registries in lower Normandy.

Béchade C, Dejardin O, Bara S, Bouvier V, Guizard AV, De Mil R, Troussard X, Launoy G, Lobbedez T.

Nephrology (Carlton). 2018 Dec;23(12):1125-1130. doi: 10.1111/nep.13091.

PMID:
28633195
15.

Usefulness of thresholds for smear review of neutropenic samples analyzed with a Sysmex XN-10 analyzer.

Ronez E, Geara C, Coito S, Jacqmin H, Cornet E, Troussard X, Chatelain B, Mullier F.

Scand J Clin Lab Invest. 2017 Oct;77(6):406-409. doi: 10.1080/00365513.2017.1334129. Epub 2017 Jun 13.

PMID:
28609162
16.

Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma.

Reboursiere E, Gac AC, Garnier A, Salaun V, Reman O, Pham AD, Cabrera Q, Khoy K, Vilque JP, Fruchart C, Chantepie S, Johnson-Ansah H, Macro M, Cheze S, Benabed K, Mear JB, Troussard X, Damaj G, Le Mauff B, Toutirais O.

Leuk Lymphoma. 2018 Jan;59(1):187-195. doi: 10.1080/10428194.2017.1321751. Epub 2017 May 31.

PMID:
28562153
17.

Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.

Collignon A, Wanquet A, Maitre E, Cornet E, Troussard X, Aurran-Schleinitz T.

Curr Oncol Rep. 2017 Apr;19(4):29. doi: 10.1007/s11912-017-0581-x. Review.

PMID:
28324286
18.

Development of a model to predict the 10-year cumulative risk of second primary cancer among cancer survivors.

Moitry M, Velten M, Trétarre B, Bara S, Daubisse-Marliac L, Lapôtre-Ledoux B, Troussard X, Molinié F, Ligier K, Woronoff AS, Bouvier V, Colonna M, Klein D, Guizard AV, Jégu J.

Cancer Epidemiol. 2017 Apr;47:35-41. doi: 10.1016/j.canep.2017.01.001. Epub 2017 Jan 21.

PMID:
28113110
19.

[Management of age-related macular degeneration].

Troussard X.

Rev Prat. 2017 Jan;67(1):96-100. French.

PMID:
30512447
20.

Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?

Le Guyader-Peyrou S, Orazio S, Dejardin O, Maynadié M, Troussard X, Monnereau A.

Haematologica. 2017 Mar;102(3):584-592. doi: 10.3324/haematol.2016.152918. Epub 2016 Dec 1.

21.

Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.

Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M, Forconi F, Gozzetti A, Ho AD, Johnston JB, Jones J, Juliusson G, Kraut E, Kreitman RJ, Larratt L, Lauria F, Lozanski G, Montserrat E, Parikh SA, Park JH, Polliack A, Quest GR, Rai KR, Ravandi F, Robak T, Saven A, Seymour JF, Tadmor T, Tallman MS, Tam C, Tiacci E, Troussard X, Zent CS, Zenz T, Zinzani PL, Falini B.

Blood. 2017 Feb 2;129(5):553-560. doi: 10.1182/blood-2016-01-689422. Epub 2016 Nov 30.

22.

Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center study.

Vautier M, de Boysson H, Creveuil C, Repesse Y, Borel-Derlon A, Troussard X, Damaj GL, Bienvenu B, Gautier P, Aouba A.

Medicine (Baltimore). 2016 Nov;95(48):e5232.

23.

Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients.

Wanquet A, Birsen R, Bonnet C, Boubaya M, Choquet S, Dupuis J, Lepretre S, Re D, Fahri J, Michallet AS, Ysebaert L, Lemal R, Lamy T, Delarue R, Troussard X, Cymbalista F, Levy V, Dietrich PY, Leblond V, Aurran-Schleinitz T.

Br J Haematol. 2017 Jan;176(1):37-49. doi: 10.1111/bjh.14387. Epub 2016 Nov 11.

PMID:
27858991
24.

Incidence and characteristics of chronic renal replacement therapy in patients with cancer: data from kidney and cancer registries in Basse-Normandie.

Béchade C, Dejardin O, Bara S, Bouvier V, Guizard AV, De Mil R, Troussard X, Lobbedez T, Launoy G.

J Nephrol. 2018 Feb;31(1):111-118. doi: 10.1007/s40620-016-0356-8. Epub 2016 Nov 4.

PMID:
27815918
25.

Traiter les formes actives de la maladie.

Troussard X.

Rev Prat. 2016 Nov;66(9):1020-1024. French.

PMID:
30512375
26.

Harmonisation of full blood count reports, recommendations of the French-speaking cellular haematology group (GFHC).

Trimoreau F, Galoisy AC, Geneviève F, Bardet V, Cornet E, Hurst JP, Lesesve JF, Leymarie V, Lusina D, Perez B, Cahn JY, Damaj G, Ugo V, Troussard X; French-Speaking Cellular Haematology Group.

J Clin Pathol. 2017 May;70(5):395-402. doi: 10.1136/jclinpath-2016-204001. Epub 2016 Oct 11.

PMID:
27729428
27.

Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.

Le Bris Y, Struski S, Guièze R, Rouvellat C, Prade N, Troussard X, Tournilhac O, Béné MC, Delabesse E, Ysebaert L.

Hematol Oncol. 2017 Dec;35(4):664-670. doi: 10.1002/hon.2349. Epub 2016 Sep 28.

PMID:
27678008
28.

SYNDROME MONONUCLÉOSIQUE.

Troussard X, Cornet É.

Rev Prat. 2016 Jun;66(6 Suppl):e275-9. French. No abstract available.

PMID:
27538339
29.

Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study.

Neumann F, Jégu J, Mougin C, Prétet JL, Guizard AV, Lapôtre-Ledoux B, Bara S, Bouvier V, Colonna M, Troussard X, Trétarre B, Grosclaude P, Velten M, Woronoff AS.

Prev Med. 2016 Sep;90:52-8. doi: 10.1016/j.ypmed.2016.06.041. Epub 2016 Jun 28.

PMID:
27370167
30.

Evaluation and optimization of the extended information process unit (E-IPU) validation module integrating the sysmex flag systems and the recommendations of the French-speaking cellular hematology group (GFHC).

Cornet E, Mullier F, Despas N, Jacqmin H, Geara C, Boubaya M, Chatelain B, Troussard X.

Scand J Clin Lab Invest. 2016 Oct;76(6):465-71. doi: 10.1080/00365513.2016.1199049. Epub 2016 Jun 27.

PMID:
27347841
31.

Prediction of patients with multiple myeloma eligible for second- or third-line treatment in France.

Rondeau V, Cornet E, Moreau P, Troussard X.

Ann Hematol. 2016 Aug;95(8):1307-13. doi: 10.1007/s00277-016-2688-9. Epub 2016 May 10.

PMID:
27165088
32.

Rituximab salvage therapy in adults with immune thrombocytopenia: retrospective study on efficacy and safety profiles.

Reboursiere E, Fouques H, Maigne G, Johnson H, Chantepie S, Gac AC, Reman O, Macro M, Benabed K, Troussard X, Damaj G, Cheze S.

Int J Hematol. 2016 Jul;104(1):85-91. doi: 10.1007/s12185-016-1992-4. Epub 2016 Apr 4.

PMID:
27040278
33.

[New insights in the treatment of chronic lymphocytic leukemia and role of the biologist in the monitoring of the treatments].

Troussard X, Cornet É.

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):176-83. doi: 10.1684/abc.2016.1125. Review. French.

34.

Cancer incidence in France over the 1980-2012 period: Hematological malignancies.

Le Guyader-Peyrou S, Belot A, Maynadié M, Binder-Foucard F, Remontet L, Troussard X, Bossard N, Monnereau A; French network of cancer registries (Francim).

Rev Epidemiol Sante Publique. 2016 Apr;64(2):103-12. doi: 10.1016/j.respe.2015.12.017. Epub 2016 Mar 10.

35.

Persistent polyclonal binucleated B-cell lymphocytosis and MECOM gene amplification.

Cornet E, Mossafa H, Courel K, Lesesve JF, Troussard X.

BMC Res Notes. 2016 Mar 2;9:138. doi: 10.1186/s13104-015-1742-3.

36.

Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5).

Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, Capocaccia R, Iwaz J, Monnereau A, Troussard X, Sant M, Maynadié M, Giorgi R; EUROCARE-5 Working Group; CENSUR Working Survival Group.

Lancet Haematol. 2015 Nov;2(11):e481-91. doi: 10.1016/S2352-3026(15)00155-6. Epub 2015 Oct 23.

PMID:
26686258
37.

[Chronic lymphocytic leukemia: a paradigm shift What is the role of the biologist in this new world?].

Troussard X.

Ann Biol Clin (Paris). 2015 Nov;73 Suppl 1:19-21. doi: 10.1684/abc.2015.1082. French. No abstract available.

PMID:
26620240
38.

Comparative study of quantitative performances between the new Sysmex XN-L (XN-550) haematology analyser and the XN-9000 in a routine laboratory.

Geara C, Cornet E, Troussard X.

Int J Lab Hematol. 2016 Feb;38(1):e10-1. doi: 10.1111/ijlh.12441. Epub 2015 Oct 28. No abstract available.

PMID:
26508402
39.

Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.

Muller J, Grosclaude P, Lapôtre-Ledoux B, Woronoff AS, Guizard AV, Bara S, Colonna M, Troussard X, Bouvier V, Trétarre B, Velten M, Jégu J.

BJU Int. 2016 Jul;118(1):53-9. doi: 10.1111/bju.13351. Epub 2015 Nov 17.

40.

Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.

De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, Visser O, Maynadié M, Marcos-Gragera R, Troussard X, Agius D, Roazzi P, Meneghini E, Monnereau A; EUROCARE-5 Working Group:.

Eur J Cancer. 2015 Oct;51(15):2254-2268. doi: 10.1016/j.ejca.2015.08.003. Epub 2015 Sep 26.

PMID:
26421827
41.

Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network.

Damaj G, Ivanoff S, Coso D, Ysaebert L, Choquet S, Houillier C, Parcelier A, Abarah W, Marjanovic Z, Gressin R, Garidi R, Diouf M, Gac AC, Dupuis J, Troussard X, Morschhauseur F, Ghesquières H, Soussain C; LYSA and LOC network, France.

Haematologica. 2015 Sep;100(9):1199-206. doi: 10.3324/haematol.2015.126110. Epub 2015 Jul 16.

42.

CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy.

Poret N, Fu Q, Guihard S, Cheok M, Miller K, Zeng G, Quesnel B, Troussard X, Galiègue-Zouitina S, Shelley CS.

Cancer Res. 2015 Sep 15;75(18):3902-11. doi: 10.1158/0008-5472.CAN-15-0893. Erratum in: Cancer Res. 2015 Dec 1;75(23):5167.

43.

New insights in the management of patients with hairy cell leukemia.

Cornet E, Damaj G, Troussard X.

Curr Opin Oncol. 2015 Sep;27(5):371-6. doi: 10.1097/CCO.0000000000000214. Review.

PMID:
26154707
44.

Chronic active Epstein-Barr virus infection with cutaneous and sinus lymphoproliferation in a white female patient with 25 years' follow-up: an original case report.

Picard C, Gouarin S, Comoz F, Barreau M, Verneuil L, Troussard X, Dompmartin A.

Br J Dermatol. 2015 Nov;173(5):1266-70. doi: 10.1111/bjd.14014. Epub 2015 Sep 8.

PMID:
26148205
45.

Evaluating abbreviated induction with fludarabine, cyclophosphamide, and dose-dense rituximab in elderly patients with chronic lymphocytic leukemia.

Dartigeas C, Van Den Neste E, Berthou C, Maisonneuve H, Leprêtre S, Dilhuydy MS, Béné MC, Nguyen-Khac F, Letestu R, Cymbalista F, De Guibert S, Aurran T, Laribi K, Vilque JP, Tournilhac O, Delmer A, Feugier P, Cazin B, Michallet AS, Lévy V, Troussard X, Delepine R, Tavernier E, Colombat P, Leblond V.

Leuk Lymphoma. 2016 Feb;57(2):328-334. doi: 10.3109/10428194.2015.1063139. Epub 2015 Sep 28.

PMID:
26140301
46.

Recurrent CDKN1B (p27) mutations in hairy cell leukemia.

Dietrich S, Hüllein J, Lee SC, Hutter B, Gonzalez D, Jayne S, Dyer MJ, Oleś M, Else M, Liu X, Słabicki M, Wu B, Troussard X, Dürig J, Andrulis M, Dearden C, von Kalle C, Granzow M, Jauch A, Fröhling S, Huber W, Meggendorfer M, Haferlach T, Ho AD, Richter D, Brors B, Glimm H, Matutes E, Abdel Wahab O, Zenz T.

Blood. 2015 Aug 20;126(8):1005-8. doi: 10.1182/blood-2015-04-643361. Epub 2015 Jun 11.

47.

Developing Molecular Signatures for Chronic Lymphocytic Leukemia.

Cornet E, Debliquis A, Rimelen V, Civic N, Docquier M, Troussard X, Drénou B, Matthes T.

PLoS One. 2015 Jun 5;10(6):e0128990. doi: 10.1371/journal.pone.0128990. eCollection 2015.

48.

Diagnosis approach of chronic lymphocytic leukemia on unstained blood smears using Raman microspectroscopy and supervised classification.

Happillon T, Untereiner V, Beljebbar A, Gobinet C, Daliphard S, Cornillet-Lefebvre P, Quinquenel A, Delmer A, Troussard X, Klossa J, Manfait M.

Analyst. 2015 Jul 7;140(13):4465-72. doi: 10.1039/c4an02085e.

PMID:
26017101
49.

Contribution of the new XN-1000 parameters NEUT-RI and NEUT-WY for managing patients with immature granulocytes.

Cornet E, Boubaya M, Troussard X.

Int J Lab Hematol. 2015 Oct;37(5):e123-6. doi: 10.1111/ijlh.12372. Epub 2015 Apr 28. No abstract available.

PMID:
25923650
50.

[Chronic B-cell lymphoproliferative disorders with hairy cells].

Troussard X, Cornet É.

Ann Biol Clin (Paris). 2015 Jul-Aug;73(4):399-406. doi: 10.1684/abc.2015.1037. French.

Supplemental Content

Loading ...
Support Center